The effects of sargramostim and filgrastim on hematopoietic cells are described. Filgrastim is a lineage-specific colonystimulating factor (CSF), mainly affecting neutrophils. In addition to enhancing ...
A retrospective cohort study design was used to analyze commercial claims data in adults with lung cancer initiated on chemotherapy from April 1, 2013, to March 30, 2015. The tool was implemented at ...
The Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) performance improvement methodology was used to implement this formulary conversion project. The key elements of the JCAHO ...
The yield of peripheral blood stem cells (PBSC) in hematological or solid tumour patients treated with high dose chemotherapy and hemopoietic growth factors No significant financial relationships to ...
The FDA approves biosimilar chemo infection risk treatment Filkri for cancer patients, expanding granulocyte ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Treatment with a molecule known as A485 can quickly and temporarily increase levels of white blood cells, a critical part of the body's immune system, an effect that is difficult to deliver with ...
Inhaled seralutinib demonstrated clinical activity in high-risk pulmonary arterial hypertension patients despite missing its primary phase 3 endpoint.
A new study that including participants from the Central Institute of Mental Health in Mannheim shows how the growth factor erythropoietin (EPO) protects and regenerates nerve cells in the brain. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results